Litcius/Paper detail

Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma

Simon Couillard, Rahul Shrimanker, Rekha Chaudhuri, Adel Mansur, Lorcan McGarvey, Liam G. Heaney, Stephen J. Fowler, Peter Bradding, Ian Pavord, Timothy Hinks

2021American Journal of Respiratory and Critical Care Medicine80 citationsDOIOpen Access PDF

Topics & Concepts

Exhaled nitric oxideMedicineAsthmaCorticosteroidNitric oxideImmunologyInternal medicineSpirometryAsthma and respiratory diseasesChronic Obstructive Pulmonary Disease (COPD) ResearchRespiratory and Cough-Related Research
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma | Litcius